Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duvelisib and Nivolumab for Richter's Syndrome and Transformed Follicular Lymphoma
NCT03892044Phase 1Completed
- Start
- Nov 2019
- Primary completion
- Feb 2024
- Countries
- 1
01
Overview
Phase 1, open-label trial of duvelisib in Richter syndrome (RS), follicular lymphoma, transformed (t-FL) and diffuse large B-cell lymphoma (DLBCL). Started Nov 2019; status: completed.
02
Drugs
duvelisib
03
Conditions
Richter syndrome (RS)follicular lymphoma, transformed (t-FL)diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT03892044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03892044.